Literature DB >> 17604935

N-acetylaspartic acid promotes oxidative stress in cerebral cortex of rats.

Carolina D Pederzolli1, Caroline P Mescka, Fernanda Scapin, Francieli J Rockenbach, Angela M Sgaravatti, Mirian B Sgarbi, Angela T S Wyse, Clóvis M D Wannmacher, Moacir Wajner, Carlos S Dutra-Filho.   

Abstract

N-acetylaspartic acid accumulates in Canavan Disease, a severe leukodystrophy characterized by swelling and spongy degeneration of the white matter of the brain. This inherited metabolic disease, caused by deficiency of the enzyme aspartoacylase, is clinically characterized by severe mental retardation, hypotonia and macrocephaly, and also generalized tonic and clonic type seizures in about half of the patients. Considering that the mechanisms of brain damage in this disease remain not fully understood, in the present study we investigated whether oxidative stress is elicited by N-acetylaspartic acid. The in vitro effect of N-acetylaspartic acid (10-80 mM) was studied on oxidative stress parameters: total radical-trapping antioxidant potential (TRAP), total antioxidant reactivity (TAR), chemiluminescence, thiobarbituric acid-reactive substances (TBA-RS), reduced glutathione content, sufhydryl content and carbonyl content in the cerebral cortex of 14-day-old rats. The effect of the acute administration of N-acetylaspartic acid (0.1-0.6 mmol/g body weight) was studied on TRAP, TAR, carbonyl content, chemiluminescence and TBA-RS. TRAP, TAR, reduced glutathione content and sulfhydryl content were significantly reduced, while chemiluminescence, TBA-RS and carbonyl content were significantly enhanced by N-acetylaspartic acid in vitro. The enhancement in TBA-RS promoted by N-acetylaspartic acid was completely prevented by ascorbic acid plus Trolox, and partially prevented by glutathione and dithiothreitol. The acute administration of N-acetylaspartic acid also significantly reduced TRAP and TAR, and significantly enhanced carbonyl content, chemiluminescence and TBA-RS. Our results indicate that N-acetylaspartic acid promotes oxidative stress by stimulating lipid peroxidation, protein oxidation and by decreasing non-enzymatic antioxidant defenses in rat brain. This could be another pathophysiological mechanism involved in Canavan Disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604935     DOI: 10.1016/j.ijdevneu.2007.04.002

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  10 in total

1.  N-acetylaspartic acid impairs enzymatic antioxidant defenses and enhances hydrogen peroxide concentration in rat brain.

Authors:  Carolina Didonet Pederzolli; Caroline Paula Mescka; Alessandra Selinger Magnusson; Kátia Bueno Deckmann; Evelise de Souza Streck; Angela Malysz Sgaravatti; Mirian Bonaldi Sgarbi; Angela T S Wyse; Clovis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2010-05-01       Impact factor: 3.584

2.  Neuroprotective role of lipoic acid against acute toxicity of N-acetylaspartic acid.

Authors:  Carolina Didonet Pederzolli; Andrea Pereira Rosa; Amanda Szekir de Oliveira; Juliana G Coelho; Débora da Luz Becker; Giovana Reche Dalazen; Tarsila Barros Moraes; Carlos S Dutra-Filho
Journal:  Mol Cell Biochem       Date:  2010-08-05       Impact factor: 3.396

3.  Making the White Matter Matters: Progress in Understanding Canavan's Disease and Therapeutic Interventions Through Eight Decades.

Authors:  Seemin S Ahmed; Guangping Gao
Journal:  JIMD Rep       Date:  2015-01-21

4.  Intracerebroventricular administration of N-acetylaspartic acid impairs antioxidant defenses and promotes protein oxidation in cerebral cortex of rats.

Authors:  Carolina Didonet Pederzolli; Francieli Juliana Rockenbach; Fernanda Rech Zanin; Nicoli Taiana Henn; Eline Coan Romagna; Angela M Sgaravatti; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Angela de Mattos Dutra; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-03-18       Impact factor: 3.584

Review 5.  The ubiquitin-proteasome system in spongiform degenerative disorders.

Authors:  Brandi R Whatley; Lian Li; Lih-Shen Chin
Journal:  Biochim Biophys Acta       Date:  2008-08-23

6.  rAAV Gene Therapy in a Canavan's Disease Mouse Model Reveals Immune Impairments and an Extended Pathology Beyond the Central Nervous System.

Authors:  Seemin Seher Ahmed; Stefan A Schattgen; Ashley E Frakes; Elif M Sikoglu; Qin Su; Jia Li; Thomas G Hampton; Andrew R Denninger; Daniel A Kirschner; Brian Kaspar; Reuben Matalon; Guangping Gao
Journal:  Mol Ther       Date:  2016-04-04       Impact factor: 11.454

Review 7.  Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair.

Authors:  Anoushka Lotun; Dominic J Gessler; Guangping Gao
Journal:  Front Cell Neurosci       Date:  2021-04-23       Impact factor: 6.147

8.  Increasing N-acetylaspartate in the Brain during Postnatal Myelination Does Not Cause the CNS Pathologies of Canavan Disease.

Authors:  Abhilash P Appu; John R Moffett; Peethambaran Arun; Sean Moran; Vikram Nambiar; Jishnu K S Krishnan; Narayanan Puthillathu; Aryan M A Namboodiri
Journal:  Front Mol Neurosci       Date:  2017-06-02       Impact factor: 5.639

9.  Identification of neurodegeneration indicators and disease progression in metachromatic leukodystrophy using quantitative NMR-based urinary metabolomics.

Authors:  Lucia Laugwitz; Laimdota Zizmare; Vidiyaah Santhanakumaran; Claire Cannet; Judith Böhringer; Jürgen G Okun; Manfred Spraul; Ingeborg Krägeloh-Mann; Samuel Groeschel; Christoph Trautwein
Journal:  JIMD Rep       Date:  2022-01-27

10.  A framework for large-scale metabolome drug profiling links coenzyme A metabolism to the toxicity of anti-cancer drug dichloroacetate.

Authors:  Sébastien Dubuis; Karin Ortmayr; Mattia Zampieri
Journal:  Commun Biol       Date:  2018-08-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.